Here are three things to know:
1. The company uses autologous bioactive cells in a range of clinical applications.
2. Royal Biologics’ Maxx-Cell is a bone marrow extraction device that does not require centrifugation. It is designed to maximize cell count yields while minimizing peripheral blood dilution.
3. Demetri Soteropoulos and Salvatore Leo co-founded Royal Biologics in 2015. Mr. Soteropoulus serves as chairman, and Mr. Leo is the CEO. Combined they have 30 years of medical device company experience.
More articles on biologics:
FDA to crackdown on ‘bogus’ stem cell treatments in 2019
Axolotl Biologix launches new regenerative fluid syringe for orthopedic wound care: 3 details
Center for Neurosciences, Orthopaedics & Spine using plasma injections to treat joint pain
